Encompass Health Corporation (EHC)
NYSE
120.92
+0.61 (+0.51%)
Closed
Aug 24, 2026
Day's Range
120.28122.40
52 wk Range
92.77127.99
Financial Statements - EHC - Encompass Health Corporation
Revenue
5.93B▲ 10.5%
Net Income
759.10M▲ 27.2%Net Margin 12.8%
EBITDA
1.40B▲ 18.3%
Free Cash Flow
439.20M▲ 21.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 5.93B | 5.37B | 4.80B | 4.34B | 4.01B | 3.56B |
| Cost of Goods | 254.40M | 3.14B | 218.30M | 202.10M | 184.20M | 171M |
| Gross Profit | 5.68B | 2.23B | 4.58B | 4.14B | 3.83B | 3.39B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 1.05B | 864.50M | 731.80M | 630.20M | 659.40M | 530.40M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 23.10M | 22.50M | 18.90M | -3.70M | 9.90M | 6.20M |
| Pre Tax Income | 953M | 749.60M | 607.20M | 450.80M | 505M | 352.90M |
| Income Tax | 192.90M | 150.20M | 132.20M | 100.10M | 101.90M | 74.70M |
| Net Income | 759.10M | 596.60M | 463M | 365.90M | 517.20M | 368.80M |
| EPS Basic | 5.62 | 4.53 | 3.51 | 2.72 | 4.15 | 2.87 |
| EPS Diluted | 5.54 | 4.46 | 3.47 | 2.7 | 4.11 | 2.85 |
| Basic Shares Outstanding | 100.50M | 99.90M | 99.50M | 99.20M | 99M | 98.60M |
| Diluted Shares Outstanding | 100.50M | 99.90M | 99.50M | 99.20M | 99M | 98.60M |
| Ebit | 1.07B | 887M | 750.70M | 626.50M | 669.30M | 536.60M |
| Ebitda | 1.40B | 1.18B | 1.02B | 871.50M | 889.90M | 744.70M |
| Net Income Continuous Operations | 760.10M | 599.40M | 475M | 350.70M | 403.10M | 278.20M |
| Minority Interests | -192.90M | -140.90M | -111M | -94.90M | -105M | -84.60M |
| Preferred Stock Dividends | 1.50M | 2.80M | 2.40M | 1.20M | 1.80M | 1M |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
